Sabinsa Corporation today announced that it has secured U.S. Patent No. 7,253,324, protecting the process for the synthesis of biologically active polyphenolic compounds by novel dealkylation. This process of aromatic poly o-demethylation is applicable in the manufacturing of polyphenols such as resveratrol, oxyresveratrol and gnetol.
"The review, acceptance and issuing of this patent by the U.S. Patent and Trademark Office was completed in only six months, which is a testament to the hard work of our scientific team and the thoroughness of the information that was submitted with the patent application on the process, scientific support and previous references on the subject," stated Muhammed Majeed, Ph.D., founder and CEO, Sabinsa Corporation. "This represents our 34th patent worldwide and underscores our continued innovation surrounding manufacturing processes for herbal extracts, phytonutrients and specialty fine chemicals."
This patent covers a wide range of applications in the multi-step synthesis of pharmaceuticals and fine chemicals. This streamlined manufacturing process enables easy access to several known polyphenols and simplifies the course of action for discovering unknown polyphenolic compounds. Sabinsa has applied this patented process to manufacture stilbene-polyphenols exhibiting various health benefits such as resveratrol, oxyresveratrol and pterostilbene.